1. Characterization of Novel Splice Variants of Zinc Finger Antiviral Protein (ZAP).
- Author
-
Li, Melody M. H., Aguilar, Eduardo G., Michailidis, Eleftherios, Pabon, Jonathan, Park, Paul, Xianfang Wu, de Jong, Ype P., Schneider, William M., Molina, Henrik, Rice, Charles M., and MacDonald, Margaret R.
- Subjects
- *
ZINC-finger proteins , *HEPATITIS B virus , *DNA viruses , *HOSTS (Biology) , *RNA viruses - Abstract
Given the unprecedented scale of the recent Ebola and Zika viral epidemics, it is crucial to understand the biology of host factors with broad antiviral action in order to develop novel therapeutic approaches. Here, we look into one such factor: zinc finger antiviral protein (ZAP) inhibits a variety of RNA and DNA viruses. Alternative splicing results in two isoforms that differ at their C termini: ZAPL (long) encodes a poly(ADP-ribose) polymerase (PARP)-like domain that is missing in ZAPS (short). Previously, it has been shown that ZAPL is more antiviral than ZAPS, while the latter is more induced by interferon (IFN). In this study, we discovered and confirmed the expression of two additional splice variants of human ZAP: ZAPXL (extralong) and ZAPM (medium). We also found two haplotypes of human ZAP. Since ZAPL and ZAPS have differential activities, we hypothesize that all four ZAP isoforms have evolved to mediate distinct antiviral and/or cellular functions. By taking a geneknockout- and-reconstitution approach, we have characterized the antiviral, translational inhibition, and IFN activation activities of individual ZAP isoforms. Our work demonstrates that ZAPL and ZAPXL are more active against alphaviruses and hepatitis B virus (HBV) than ZAPS and ZAPM and elucidates the effects of splice variants on the action of a broad-spectrum antiviral factor. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF